Linker Information
General Information of This Linker
| Linker ID |
LIN00025
|
|||||
|---|---|---|---|---|---|---|
| Linker Name |
NODAGA
|
|||||
| Structure |
|
|||||
| Formula |
C10H16N2O7
|
|||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 276.24 | ||||
| Lipid-water partition coefficient (xlogp) | -4.3 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 5 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 8 | |||||
| Rotatable Bond Count (rotbonds) | 9 | |||||
| PubChem CID | ||||||
| Canonical smiles |
C(CC(=O)NC(CCC(=O)O)C(=O)O)C(C(=O)O)N
|
|||||
| InChI |
InChI=1S/C10H16N2O7/c11-5(9(16)17)1-3-7(13)12-6(10(18)19)2-4-8(14)15/h5-6H,1-4,11H2,(H,12,13)(H,14,15)(H,16,17)(H,18,19)
|
|||||
| InChIKey |
OWQDWQKWSLFFFR-UHFFFAOYSA-N
|
|||||
| IUPAC Name |
2-[(4-amino-4-carboxybutanoyl)amino]pentanedioic acid
|
|||||
Each Peptide-drug Conjugate Related to This Linker
Full Information of The Activity Data of The PDC(s) Related to This Linker
68Ga-NODAGA-E[c(RGDyK)]2 [Phase 3]
Discovered Using Cell Line-derived Xenograft Model
| Experiment 1 Reporting the Activity Data of This PDC | [1] | ||||
| Indication | Glioblastoma | ||||
| Efficacy Data | Radiochemical purity |
89%-99%
|
|||
| In Vivo Model | Nude mice bearing either human glioblastoma (U87MG)/human neuroendocrine (H727) xenograft tumors. | ||||
64Cu-NODAGA-E[c(RGDyK)]2 [Investigative]
Discovered Using Cell Line-derived Xenograft Model
| Experiment 1 Reporting the Activity Data of This PDC | [1] | ||||
| Indication | Glioblastoma | ||||
| Efficacy Data | Radiochemical purity |
92%-99%
|
|||
| In Vivo Model | Nude mice bearing either human glioblastoma (U87MG)/human neuroendocrine (H727) xenograft tumors. | ||||
References
